Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | NPBWR1 | P48145 | 4/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.30 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13989336 | 0.88 | TSHR (0.38) | TSHRALDH1A1NPBWR1RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL4874636 | 0.80 | HTR1A (0.37) | HTR1AMAOASLC6A2SLC6A4ADRA1A | |
| Hydrochloric Acid SCHEMBL4874070 | 0.78 | TSHR (0.38) | HTR1AMAOASLC6A2SLC6A4ADRA1A | |
| Hydrochloric Acid SCHEMBL4863978 | 0.76 | TSHR (0.42) | HTR1AMAOASLC6A2SLC6A4ADRA1A | |
| Hydrochloric Acid SCHEMBL4867530 | 0.76 | TSHR (0.41) | HTR1AMAOASLC6A2SLC6A4ADRA1A | |
| Hydrochloric Acid SCHEMBL4872402 | 0.70 | HTR1A (0.33) | HTR1AMAOASLC6A2SLC6A4ADRA1A | |
| SCHEMBL6332742 | 0.68 | RAB9A (0.43) | LMNAALDH1A1TERTRAB9AKDM4E | |
| SCHEMBL11527611 | 0.66 | RAB9A (0.41) | LMNAALDH1A1TERTRAB9AKDM4E | |
| SCHEMBL6002694 | 0.66 | TSHR (0.47) | TSHRALDH1A1NPBWR1RAB9APOLB | |
| SCHEMBL6554349 | 0.65 | CHAT (0.49) | LMNAALDH1A1TERTRAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070056120-A1 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2007-03-15 | — | — | US | claimed |
| US-7462204-B2 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | WELLA AG (DE) | 2008-12-09 | — | — | US | disclosed |
| US-20070056120-A1 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2007-03-15 | — | — | US | disclosed |
| EP-1687280-A1 | CATIONIC DIAMINOPYRAZOLES, A METHOD FOR THE PRODUCTION THEREOF AND DYES CONTAINING THESE COMPOUNDS | Wella Aktiengesellschaft (DE) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005051918-A1 | CATIONIC DIAMINOPYRAZOLES, A METHOD FOR THE PRODUCTION THEREOF AND DYES CONTAINING THESE COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2005-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070056120-A1 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | KRT18, DSP, TUBA4A | HTR1A 3416/4885MAOA 1189/4885SLC6A2 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.